BioCryst Pharmaceuticals shares owned by DAFNA Capital Management
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by DAFNA Capital Management
from 13F filings
Historical chart of DAFNA Capital Management investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by DAFNA Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.7M | 218k | 7.59 |
| 2025-06-30 | $2.0M | 218k | 8.96 |
| 2025-03-31 | $4.2M | 558k | 7.50 |
| 2024-12-31 | $5.0M | 667k | 7.52 |
| 2024-09-30 | $5.1M | 667k | 7.60 |
| 2024-06-30 | $4.4M | 705k | 6.18 |
| 2024-03-31 | $3.6M | 710k | 5.08 |
| 2023-12-31 | $4.2M | 710k | 5.99 |
| 2023-09-30 | $4.6M | 652k | 7.08 |
| 2023-06-30 | $4.0M | 569k | 7.04 |
| 2023-03-31 | $4.6M | 552k | 8.34 |
| 2022-12-31 | $2.9M | 251k | 11.48 |
| 2020-09-30 | $2.6M | 749k | 3.44 |
| 2020-06-30 | $3.5M | 744k | 4.76 |
| 2020-03-31 | $958k | 479k | 2.00 |
| 2019-12-31 | $1.8M | 514k | 3.45 |
| 2019-09-30 | $1.4M | 483k | 2.87 |
| 2019-06-30 | $1.6M | 411k | 3.79 |
| 2019-03-31 | $4.1M | 498k | 8.14 |
| 2018-12-31 | $3.7M | 464k | 8.07 |
| 2018-09-30 | $5.0M | 652k | 7.63 |
| 2018-06-30 | $3.5M | 605k | 5.73 |
| 2018-03-31 | $4.6M | 975k | 4.77 |
| 2017-12-31 | $5.9M | 1.2M | 4.91 |
| 2017-09-30 | $6.3M | 1.2M | 5.24 |
| 2017-06-30 | $3.3M | 591k | 5.56 |
| 2017-03-31 | $4.5M | 541k | 8.40 |
| 2016-12-31 | $417k | 66k | 6.33 |
| 2016-03-31 | $424k | 150k | 2.83 |
| 2015-12-31 | $2.6M | 256k | 10.32 |
| 2015-09-30 | $2.9M | 259k | 11.40 |
| 2015-06-30 | $3.3M | 222k | 14.93 |
| 2015-03-31 | $1.5M | 167k | 9.03 |
| 2014-12-31 | $2.0M | 167k | 12.16 |
| 2014-09-30 | $747k | 76k | 9.78 |